Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

724890.pdf (1.54 MB)

Document type

Article

Version

Published version

Publication date

2022-05

Publication license

cc by-nc-nd (c) Luque, Juan et al., 2022
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/194221

CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1111/cge.14113

Abstract

CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research.

Subject

Malalties rares, Diagnòstic, Epidemiologia, Genètica

Subject (English)

Rare diseases, Diagnosis, Epidemiology, Genetics

Citation

Collections

Articles publicats en revistes (Genètica, Microbiologia i Estadística)
Articles publicats en revistes (Biomedicina)
Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Citation

LUQUE, Juan, et al. CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative. Clinical Genetics. 2022. Vol. 101, num. 5-6, pags. 481-493. ISSN 0009-9163. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/194221

Export metadata

JSON - METS

Share record